Exicure (XCUR) Shares Outstanding (Diluted Average) (2019 - 2026)

Exicure (XCUR) reported Shares Outstanding (Diluted Average) of $6.4 million for Q1 2026, up 3.09% on a YoY basis from $6.2 million in Q1 2025, and up 1.22% quarter-over-quarter from $6.3 million in Q4 2025.

Exicure (XCUR) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends

Exicure has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $6.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 3.09% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 3.09% YoY), and the FY2025 full-year result was $6.3 million, up 208.19% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $6.4 million, up from $6.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $7.4 million in Q2 2023, with the low at $1.6 million in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $4.3 million across 5 years, with a median of $4.6 million in 2022.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) tumbled 95.41% — and 2025, when it surged 261.56%.
  • Exicure's Shares Outstanding (Diluted Average) stood at $4.6 million in 2022, then plunged by 65.3% to $1.6 million in 2023, then gained by 27.48% to $2.0 million in 2024, then soared by 208.19% to $6.3 million in 2025, then advanced by 1.22% to $6.4 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $6.4 million (Q1 2026), $6.3 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 256.30 Mn
9 Abivax 94.37 Bn 94.37 Bn - 92.44 Mn
10 Exicure 19.38 Mn 16.77 Mn - 6.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.37 Mn
Dec 31, 2025 6.30 Mn
Sep 30, 2025 6.32 Mn
Jun 30, 2025 6.26 Mn
Mar 31, 2025 6.18 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 1.60 Mn
Sep 30, 2023 1.73 Mn
Jun 30, 2023 7.37 Mn
Mar 31, 2023 6.29 Mn
Dec 31, 2022 4.62 Mn
Sep 30, 2022 4.96 Mn
Jun 30, 2022 4.50 Mn
Mar 31, 2022 4.03 Mn
Dec 31, 2021 2.95 Mn
Sep 30, 2021 2.93 Mn
Jun 30, 2021 2.93 Mn